Table 1.

Recommendations for use of CDT and PCDT

FactorConsider CDT/PCDTDo not use CDT/PCDT
Risk of bleeding No bleeding contraindications Active bleeding; recent obstetrical delivery; recent (<7-14 days) major surgery, trauma, or other invasive procedure; previous hemorrhagic stroke or presence of lesions in critical locations like central nervous system; uncontrolled hypertension 
Clinical severity Acute limb threat (urgent) or rapidly progressive IVC thrombosis; severe symptoms/physical limitation despite initial anticoagulation Routine first-line DVT therapy with nonthreatened limb; asymptomatic or mildly symptomatic 
Anatomic extent Iliofemoral DVT (higher risk for PTS and severe PTS) DVT limited to calf, popliteal, femoral veins 
Symptom duration Acute: <14 days (clot likely to lyse) Chronic: >28 days (clot will not lyse) 
Other factors Life expectancy >l year; walked at baseline; few comorbidities Age >65 years; nonambulatory before the DVT; many comorbidities 
FactorConsider CDT/PCDTDo not use CDT/PCDT
Risk of bleeding No bleeding contraindications Active bleeding; recent obstetrical delivery; recent (<7-14 days) major surgery, trauma, or other invasive procedure; previous hemorrhagic stroke or presence of lesions in critical locations like central nervous system; uncontrolled hypertension 
Clinical severity Acute limb threat (urgent) or rapidly progressive IVC thrombosis; severe symptoms/physical limitation despite initial anticoagulation Routine first-line DVT therapy with nonthreatened limb; asymptomatic or mildly symptomatic 
Anatomic extent Iliofemoral DVT (higher risk for PTS and severe PTS) DVT limited to calf, popliteal, femoral veins 
Symptom duration Acute: <14 days (clot likely to lyse) Chronic: >28 days (clot will not lyse) 
Other factors Life expectancy >l year; walked at baseline; few comorbidities Age >65 years; nonambulatory before the DVT; many comorbidities 

IVC, inferior vena cava.

Close Modal

or Create an Account

Close Modal
Close Modal